Page last updated: 2024-10-22

anthralin and Adverse Drug Event

anthralin has been researched along with Adverse Drug Event in 2 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Research Excerpts

ExcerptRelevanceReference
"Drugs that have been associated with the precipitation or exacerbation of psoriasis include lithium, beta adrenergic receptor blocking agents, and antimalarials."4.77Drugs in exacerbation of psoriasis. ( Abel, EA; DiCicco, LM; Farber, EM; Fraki, JE; Orenberg, EK, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgan, RE1
van Staden, CJ1
Chen, Y1
Kalyanaraman, N1
Kalanzi, J1
Dunn, RT1
Afshari, CA1
Hamadeh, HK1
Abel, EA1
DiCicco, LM1
Orenberg, EK1
Fraki, JE1
Farber, EM1

Reviews

1 review available for anthralin and Adverse Drug Event

ArticleYear
Drugs in exacerbation of psoriasis.
    Journal of the American Academy of Dermatology, 1986, Volume: 15, Issue:5 Pt 1

    Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Anthralin; Anti-Inflammatory Agents, Non-Stero

1986

Other Studies

1 other study available for anthralin and Adverse Drug Event

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily

2013